Issue 2/2020
Current and Future Biologicals in Atopic Diseases - Cytokine Targets
Content (10 Articles)
Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
Aarti Agarwal, Derek Spath, David A. Sherris, Hirohito Kita, Jens U. Ponikau
Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment
Shelly Choudhury, Susan Baker
Asthma Phenotypes as a Guide for Current and Future Biologic Therapies
Daniel Hamilton, Heather Lehman
Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends
Lixia Gao, Li Wang, Elena Woo, XiaoSong He, GaoXiang Yang, Christopher Bowlus, Patrick S.C Leung, M. Eric Gershwin
The Current State of Biologic Therapies for Treatment of Refractory Asthma
Matthew Mavissakalian, Sean Brady
Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis
Peter Ip Fung Chun, Heather Lehman
Immunologic Adverse Effects of Biologics for the Treatment of Atopy
Vivian Aranez, Julian Ambrus Jr
Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions
Aasha Harish, Stanley A. Schwartz
Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
Jiao Jiang, Ming Zhao, Christopher Chang, Haijing Wu, Qianjin Lu
Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions
Aasha Harish, Stanley A. Schwartz